

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 6.06583743 |
| 2 | positive regulation by symbiont of host defense response (GO:0052509) | 4.74534916 |
| 3 | modulation by symbiont of host defense response (GO:0052031) | 4.74534916 |
| 4 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.74534916 |
| 5 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.74534916 |
| 6 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.74534916 |
| 7 | modulation by symbiont of host immune response (GO:0052553) | 4.74534916 |
| 8 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.67833783 |
| 9 | cellular response to virus (GO:0098586) | 4.60843685 |
| 10 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.55156217 |
| 11 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.55156217 |
| 12 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.50967759 |
| 13 | positive thymic T cell selection (GO:0045059) | 4.49933794 |
| 14 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.42085648 |
| 15 | response to peptidoglycan (GO:0032494) | 4.35894905 |
| 16 | neutrophil activation involved in immune response (GO:0002283) | 4.20235317 |
| 17 | macrophage activation involved in immune response (GO:0002281) | 4.04932638 |
| 18 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.04806080 |
| 19 | NIK/NF-kappaB signaling (GO:0038061) | 4.04083755 |
| 20 | detection of bacterium (GO:0016045) | 3.87075534 |
| 21 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.85102934 |
| 22 | detection of other organism (GO:0098543) | 3.78600852 |
| 23 | regulation of gamma-delta T cell activation (GO:0046643) | 3.74810684 |
| 24 | positive regulation of interferon-alpha production (GO:0032727) | 3.71050545 |
| 25 | negative thymic T cell selection (GO:0045060) | 3.68983154 |
| 26 | response to type I interferon (GO:0034340) | 3.68818039 |
| 27 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.66053093 |
| 28 | negative T cell selection (GO:0043383) | 3.65273112 |
| 29 | regulation of mast cell degranulation (GO:0043304) | 3.60135564 |
| 30 | positive regulation of B cell differentiation (GO:0045579) | 3.57703035 |
| 31 | thymic T cell selection (GO:0045061) | 3.56955777 |
| 32 | type I interferon signaling pathway (GO:0060337) | 3.56059154 |
| 33 | cellular response to type I interferon (GO:0071357) | 3.56059154 |
| 34 | regulation of interferon-alpha production (GO:0032647) | 3.52334442 |
| 35 | immunoglobulin mediated immune response (GO:0016064) | 3.48955132 |
| 36 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.48443055 |
| 37 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.41833526 |
| 38 | germinal center formation (GO:0002467) | 3.35142155 |
| 39 | regulation of T cell tolerance induction (GO:0002664) | 3.33465258 |
| 40 | regulation of leukocyte degranulation (GO:0043300) | 3.32978155 |
| 41 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.31971274 |
| 42 | positive T cell selection (GO:0043368) | 3.27708059 |
| 43 | regulation of B cell differentiation (GO:0045577) | 3.26409503 |
| 44 | leukocyte aggregation (GO:0070486) | 3.23179235 |
| 45 | signal complex assembly (GO:0007172) | 3.21046576 |
| 46 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.20324595 |
| 47 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.20018609 |
| 48 | T cell migration (GO:0072678) | 3.19814624 |
| 49 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.18507086 |
| 50 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.18141046 |
| 51 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.15412836 |
| 52 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.15207660 |
| 53 | T cell selection (GO:0045058) | 3.14311769 |
| 54 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.10876018 |
| 55 | response to host immune response (GO:0052572) | 3.08355187 |
| 56 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.08355187 |
| 57 | granulocyte activation (GO:0036230) | 3.08248258 |
| 58 | B cell mediated immunity (GO:0019724) | 3.07270813 |
| 59 | detection of external biotic stimulus (GO:0098581) | 3.05115787 |
| 60 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.01364781 |
| 61 | cellular response to zinc ion (GO:0071294) | 2.97325572 |
| 62 | defense response to protozoan (GO:0042832) | 2.94625236 |
| 63 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.92585851 |
| 64 | response to host (GO:0075136) | 2.92585851 |
| 65 | response to host defenses (GO:0052200) | 2.92585851 |
| 66 | mannose metabolic process (GO:0006013) | 2.90481155 |
| 67 | megakaryocyte development (GO:0035855) | 2.88993188 |
| 68 | negative regulation of cell killing (GO:0031342) | 2.87083769 |
| 69 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.87083769 |
| 70 | response to interleukin-15 (GO:0070672) | 2.86608648 |
| 71 | modulation by virus of host process (GO:0019054) | 2.86495294 |
| 72 | regulation of response to interferon-gamma (GO:0060330) | 2.86114590 |
| 73 | negative regulation of T cell mediated immunity (GO:0002710) | 2.85695728 |
| 74 | negative regulation of granulocyte differentiation (GO:0030853) | 2.85343290 |
| 75 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.83271570 |
| 76 | myeloid cell activation involved in immune response (GO:0002275) | 2.81901549 |
| 77 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.81794240 |
| 78 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.81794240 |
| 79 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.80082056 |
| 80 | modulation by symbiont of host cellular process (GO:0044068) | 2.78696100 |
| 81 | response to protozoan (GO:0001562) | 2.78620665 |
| 82 | cellular extravasation (GO:0045123) | 2.78487341 |
| 83 | regulation of regulated secretory pathway (GO:1903305) | 2.78297088 |
| 84 | positive regulation of cytokine-mediated signaling pathway (GO:0001961) | 2.77783343 |
| 85 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.77166910 |
| 86 | positive regulation of humoral immune response (GO:0002922) | 2.75192393 |
| 87 | positive regulation of interferon-beta production (GO:0032728) | 2.74740483 |
| 88 | positive regulation of tolerance induction (GO:0002645) | 2.69872400 |
| 89 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.69750708 |
| 90 | cellular response to interleukin-15 (GO:0071350) | 2.67347694 |
| 91 | regulation of antigen processing and presentation (GO:0002577) | 2.66797971 |
| 92 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.66553781 |
| 93 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.66247402 |
| 94 | positive regulation of response to cytokine stimulus (GO:0060760) | 2.66206359 |
| 95 | activation of MAPKKK activity (GO:0000185) | 2.65650003 |
| 96 | negative regulation of phagocytosis (GO:0050765) | 2.64900819 |
| 97 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.64787252 |
| 98 | detection of biotic stimulus (GO:0009595) | 2.64372534 |
| 99 | Peyers patch development (GO:0048541) | 2.63630918 |
| 100 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.63630918 |
| 101 | regulation of defense response to virus by host (GO:0050691) | 2.62731926 |
| 102 | macrophage activation (GO:0042116) | 2.62254967 |
| 103 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.61919346 |
| 104 | respiratory burst (GO:0045730) | 2.60153169 |
| 105 | positive regulation of mast cell activation (GO:0033005) | 2.59442728 |
| 106 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.58420467 |
| 107 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.58360427 |
| 108 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.57030619 |
| 109 | regulation of tolerance induction (GO:0002643) | 2.53122061 |
| 110 | response to muramyl dipeptide (GO:0032495) | 2.51696175 |
| 111 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.50523236 |
| 112 | cellular response to dsRNA (GO:0071359) | 2.49368707 |
| 113 | B cell receptor signaling pathway (GO:0050853) | 2.49322795 |
| 114 | regulation of hypersensitivity (GO:0002883) | 2.49030862 |
| 115 | leukocyte cell-cell adhesion (GO:0007159) | 2.47572368 |
| 116 | regulation of monocyte differentiation (GO:0045655) | 2.46965201 |
| 117 | myeloid dendritic cell activation (GO:0001773) | 2.46772450 |
| 118 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.46015575 |
| 119 | natural killer cell activation (GO:0030101) | 2.44861672 |
| 120 | DNA deamination (GO:0045006) | 2.42712534 |
| 121 | regulation of RIG-I signaling pathway (GO:0039535) | 2.41730342 |
| 122 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.40403248 |
| 123 | interferon-gamma production (GO:0032609) | 2.39240217 |
| 124 | hepatocyte apoptotic process (GO:0097284) | 2.38805776 |
| 125 | myeloid dendritic cell differentiation (GO:0043011) | 2.36831920 |
| 126 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.36552140 |
| 127 | sequestering of actin monomers (GO:0042989) | 2.36386019 |
| 128 | negative regulation of type I interferon production (GO:0032480) | 2.35359792 |
| 129 | positive regulation of antigen processing and presentation (GO:0002579) | 2.34819237 |
| 130 | T cell receptor signaling pathway (GO:0050852) | 2.34699790 |
| 131 | cytoplasmic pattern recognition receptor signaling pathway (GO:0002753) | 2.32663886 |
| 132 | tolerance induction (GO:0002507) | 2.32153984 |
| 133 | negative regulation of innate immune response (GO:0045824) | 2.32068156 |
| 134 | T cell costimulation (GO:0031295) | 2.31426042 |
| 135 | regulation of interferon-beta production (GO:0032648) | 2.31266275 |
| 136 | positive regulation of interleukin-2 production (GO:0032743) | 2.31212141 |
| 137 | regulation of necroptotic process (GO:0060544) | 2.28538339 |
| 138 | positive regulation of isotype switching (GO:0045830) | 2.27039487 |
| 139 | natural killer cell differentiation (GO:0001779) | 2.26749900 |
| 140 | lymphocyte costimulation (GO:0031294) | 2.25618691 |
| 141 | cytokine biosynthetic process (GO:0042089) | 2.23583897 |
| 142 | positive regulation of lamellipodium assembly (GO:0010592) | 2.22886184 |
| 143 | T cell homeostasis (GO:0043029) | 2.20517283 |
| 144 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.16113132 |
| 145 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.15750628 |
| 146 | neutrophil activation (GO:0042119) | 2.14429304 |
| 147 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.14381812 |
| 148 | negative regulation of interleukin-12 production (GO:0032695) | 2.14215423 |
| 149 | cellular response to interferon-gamma (GO:0071346) | 2.14119339 |
| 150 | lymphocyte homeostasis (GO:0002260) | 2.13601303 |
| 151 | leukocyte apoptotic process (GO:0071887) | 2.13305774 |
| 152 | positive regulation of T cell differentiation in thymus (GO:0033089) | 2.13047037 |
| 153 | positive regulation of erythrocyte differentiation (GO:0045648) | 2.12667336 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.83387586 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.80601661 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.15482903 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.95436546 |
| 5 | MYC_22102868_ChIP-Seq_BL_Human | 2.91572806 |
| 6 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.81819910 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.71622716 |
| 8 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.65308219 |
| 9 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.55882102 |
| 10 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.50514089 |
| 11 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.45989850 |
| 12 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.44424465 |
| 13 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.15446710 |
| 14 | MAF_26560356_Chip-Seq_TH1_Human | 2.12838184 |
| 15 | UTX_26944678_Chip-Seq_JUKART_Human | 2.08122198 |
| 16 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.06926734 |
| 17 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.02546965 |
| 18 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.01836417 |
| 19 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.00312214 |
| 20 | MYB_26560356_Chip-Seq_TH2_Human | 1.97678146 |
| 21 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.95082766 |
| 22 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.92590905 |
| 23 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.87747089 |
| 24 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.83512322 |
| 25 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.80999181 |
| 26 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.78552096 |
| 27 | * MYB_26560356_Chip-Seq_TH1_Human | 1.78534383 |
| 28 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.78212557 |
| 29 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.74382870 |
| 30 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.74149357 |
| 31 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.73744492 |
| 32 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.72493641 |
| 33 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.71197758 |
| 34 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.70411589 |
| 35 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.67578986 |
| 36 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.67490042 |
| 37 | * P68_20966046_ChIP-Seq_HELA_Human | 1.64899434 |
| 38 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.63263261 |
| 39 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.63173534 |
| 40 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.62458272 |
| 41 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.60350614 |
| 42 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.60048784 |
| 43 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.56728455 |
| 44 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.55415900 |
| 45 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.55260153 |
| 46 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.54550653 |
| 47 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.54429584 |
| 48 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.53306588 |
| 49 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52194811 |
| 50 | MAF_26560356_Chip-Seq_TH2_Human | 1.51818340 |
| 51 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50595257 |
| 52 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.49527338 |
| 53 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.49160542 |
| 54 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.47462129 |
| 55 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.46732867 |
| 56 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.46386898 |
| 57 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.46053208 |
| 58 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.44732457 |
| 59 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.43911655 |
| 60 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.43129694 |
| 61 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.42028937 |
| 62 | KDM2B_26808549_Chip-Seq_K562_Human | 1.41515475 |
| 63 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.41418236 |
| 64 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.36612823 |
| 65 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.33941413 |
| 66 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.30698621 |
| 67 | * CIITA_25753668_ChIP-Seq_RAJI_Human | 1.30438582 |
| 68 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.30336069 |
| 69 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.29179128 |
| 70 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.26935145 |
| 71 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.26265692 |
| 72 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.26086181 |
| 73 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25172402 |
| 74 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.24018458 |
| 75 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.21909069 |
| 76 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.21206110 |
| 77 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.18936323 |
| 78 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.17710279 |
| 79 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.17458506 |
| 80 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.17124714 |
| 81 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.17062316 |
| 82 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.16742406 |
| 83 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.16505824 |
| 84 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.16185468 |
| 85 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.15708294 |
| 86 | * CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.15616218 |
| 87 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.14777066 |
| 88 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.14560666 |
| 89 | SPI1_23127762_ChIP-Seq_K562_Human | 1.14403689 |
| 90 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.14347285 |
| 91 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.14283007 |
| 92 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.12050250 |
| 93 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.09933501 |
| 94 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.09015738 |
| 95 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.08867443 |
| 96 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.08783145 |
| 97 | GATA1_19941826_ChIP-Seq_K562_Human | 1.08134950 |
| 98 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07796421 |
| 99 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.07640661 |
| 100 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.07512047 |
| 101 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.06658503 |
| 102 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.06071602 |
| 103 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.05306432 |
| 104 | * CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.03928117 |
| 105 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.03879416 |
| 106 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.03153441 |
| 107 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.02575938 |
| 108 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.02285379 |
| 109 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.02243544 |
| 110 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.02161245 |
| 111 | SA1_27219007_Chip-Seq_Bcells_Human | 1.00901313 |
| 112 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.00843669 |
| 113 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.98446277 |
| 114 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97766983 |
| 115 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.95792819 |
| 116 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.95627675 |
| 117 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.94015228 |
| 118 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93376822 |
| 119 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.93090698 |
| 120 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.92654589 |
| 121 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.90021625 |
| 122 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89002617 |
| 123 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.88913507 |
| 124 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.88190285 |
| 125 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.87998803 |
| 126 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.87846712 |
| 127 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.87815701 |
| 128 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.86687413 |
| 129 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.85888718 |
| 130 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.85843084 |
| 131 | * XRN2_22483619_ChIP-Seq_HELA_Human | 0.85439266 |
| 132 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.85152786 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.32067644 |
| 2 | MP0000685_abnormal_immune_system | 3.20171354 |
| 3 | MP0005671_abnormal_response_to | 2.84816258 |
| 4 | MP0003763_abnormal_thymus_physiology | 2.68357744 |
| 5 | MP0009785_altered_susceptibility_to | 2.59581533 |
| 6 | MP0001800_abnormal_humoral_immune | 2.47352104 |
| 7 | MP0002166_altered_tumor_susceptibility | 2.39260458 |
| 8 | MP0005387_immune_system_phenotype | 2.34154633 |
| 9 | MP0001790_abnormal_immune_system | 2.34154633 |
| 10 | MP0003436_decreased_susceptibility_to | 2.34090529 |
| 11 | MP0002396_abnormal_hematopoietic_system | 2.30175961 |
| 12 | MP0003172_abnormal_lysosome_physiology | 2.29600973 |
| 13 | MP0005025_abnormal_response_to | 2.14303535 |
| 14 | MP0002452_abnormal_antigen_presenting | 2.13743377 |
| 15 | MP0005451_abnormal_body_composition | 2.10742049 |
| 16 | MP0002723_abnormal_immune_serum | 2.10557788 |
| 17 | MP0008260_abnormal_autophagy | 2.09399470 |
| 18 | MP0005000_abnormal_immune_tolerance | 2.08823918 |
| 19 | MP0002420_abnormal_adaptive_immunity | 2.05436407 |
| 20 | MP0001819_abnormal_immune_cell | 2.04418072 |
| 21 | MP0001873_stomach_inflammation | 2.01463664 |
| 22 | MP0002398_abnormal_bone_marrow | 2.01200231 |
| 23 | MP0002405_respiratory_system_inflammati | 1.95831316 |
| 24 | MP0004947_skin_inflammation | 1.89201652 |
| 25 | MP0002006_tumorigenesis | 1.81849509 |
| 26 | MP0000716_abnormal_immune_system | 1.81583600 |
| 27 | MP0002419_abnormal_innate_immunity | 1.80884108 |
| 28 | MP0002138_abnormal_hepatobiliary_system | 1.80210829 |
| 29 | MP0006082_CNS_inflammation | 1.78913304 |
| 30 | MP0003693_abnormal_embryo_hatching | 1.77542077 |
| 31 | MP0009333_abnormal_splenocyte_physiolog | 1.76767675 |
| 32 | MP0003724_increased_susceptibility_to | 1.70756692 |
| 33 | MP0002722_abnormal_immune_system | 1.69761027 |
| 34 | MP0010155_abnormal_intestine_physiology | 1.68652352 |
| 35 | MP0001853_heart_inflammation | 1.67926765 |
| 36 | MP0002148_abnormal_hypersensitivity_rea | 1.67817088 |
| 37 | MP0000689_abnormal_spleen_morphology | 1.67241065 |
| 38 | MP0009278_abnormal_bone_marrow | 1.66517485 |
| 39 | MP0005397_hematopoietic_system_phenotyp | 1.65746549 |
| 40 | MP0001545_abnormal_hematopoietic_system | 1.65746549 |
| 41 | MP0005464_abnormal_platelet_physiology | 1.63540141 |
| 42 | MP0010352_gastrointestinal_tract_polyps | 1.62272120 |
| 43 | MP0002429_abnormal_blood_cell | 1.61319831 |
| 44 | MP0000703_abnormal_thymus_morphology | 1.47599898 |
| 45 | MP0003705_abnormal_hypodermis_morpholog | 1.44771138 |
| 46 | MP0000678_abnormal_parathyroid_gland | 1.43969830 |
| 47 | MP0000465_gastrointestinal_hemorrhage | 1.39943962 |
| 48 | MP0003303_peritoneal_inflammation | 1.39677221 |
| 49 | MP0001845_abnormal_inflammatory_respons | 1.38733395 |
| 50 | MP0004381_abnormal_hair_follicle | 1.33235806 |
| 51 | MP0000490_abnormal_crypts_of | 1.33041982 |
| 52 | MP0000858_altered_metastatic_potential | 1.33013033 |
| 53 | MP0003191_abnormal_cellular_cholesterol | 1.31366221 |
| 54 | MP0004808_abnormal_hematopoietic_stem | 1.30168208 |
| 55 | MP0008469_abnormal_protein_level | 1.26524866 |
| 56 | MP0002933_joint_inflammation | 1.23940763 |
| 57 | MP0004510_myositis | 1.21818571 |
| 58 | MP0008057_abnormal_DNA_replication | 1.20593638 |
| 59 | MP0009840_abnormal_foam_cell | 1.20402917 |
| 60 | MP0005023_abnormal_wound_healing | 1.19994746 |
| 61 | MP0002998_abnormal_bone_remodeling | 1.16669760 |
| 62 | MP0003077_abnormal_cell_cycle | 1.16418575 |
| 63 | MP0003300_gastrointestinal_ulcer | 1.15774526 |
| 64 | MP0003866_abnormal_defecation | 1.15655518 |
| 65 | MP0005075_abnormal_melanosome_morpholog | 1.14034302 |
| 66 | MP0004858_abnormal_nervous_system | 1.10675595 |
| 67 | MP0001851_eye_inflammation | 1.09311347 |
| 68 | MP0010094_abnormal_chromosome_stability | 1.07939977 |
| 69 | MP0001533_abnormal_skeleton_physiology | 1.07860414 |
| 70 | MP0005076_abnormal_cell_differentiation | 1.06823691 |
| 71 | MP0002019_abnormal_tumor_incidence | 1.05261388 |
| 72 | MP0003075_altered_response_to | 1.04288704 |
| 73 | MP0004185_abnormal_adipocyte_glucose | 1.04242880 |
| 74 | MP0002254_reproductive_system_inflammat | 1.03339222 |
| 75 | MP0005365_abnormal_bile_salt | 1.02551725 |
| 76 | MP0003111_abnormal_nucleus_morphology | 1.02491734 |
| 77 | MP0005310_abnormal_salivary_gland | 1.02400619 |
| 78 | MP0002249_abnormal_larynx_morphology | 1.00479179 |
| 79 | MP0003183_abnormal_peptide_metabolism | 0.96944252 |
| 80 | MP0000609_abnormal_liver_physiology | 0.96358833 |
| 81 | MP0003011_delayed_dark_adaptation | 0.95508364 |
| 82 | MP0003448_altered_tumor_morphology | 0.94218701 |
| 83 | MP0001348_abnormal_lacrimal_gland | 0.93897877 |
| 84 | MP0005390_skeleton_phenotype | 0.93543317 |
| 85 | MP0003806_abnormal_nucleotide_metabolis | 0.93155762 |
| 86 | MP0002132_abnormal_respiratory_system | 0.92703221 |
| 87 | MP0003315_abnormal_perineum_morphology | 0.89081027 |
| 88 | MP0002653_abnormal_ependyma_morphology | 0.89061990 |
| 89 | MP0003453_abnormal_keratinocyte_physiol | 0.88885806 |
| 90 | MP0005166_decreased_susceptibility_to | 0.88124284 |
| 91 | MP0009764_decreased_sensitivity_to | 0.85825951 |
| 92 | MP0003566_abnormal_cell_adhesion | 0.85818301 |
| 93 | MP0005360_urolithiasis | 0.85540470 |
| 94 | MP0000681_abnormal_thyroid_gland | 0.85249426 |
| 95 | MP0002277_abnormal_respiratory_mucosa | 0.85017385 |
| 96 | MP0003656_abnormal_erythrocyte_physiolo | 0.84602488 |
| 97 | MP0008007_abnormal_cellular_replicative | 0.83478287 |
| 98 | MP0003252_abnormal_bile_duct | 0.82274656 |
| 99 | MP0005670_abnormal_white_adipose | 0.82156164 |
| 100 | MP0001663_abnormal_digestive_system | 0.81118274 |
| 101 | MP0008058_abnormal_DNA_repair | 0.79717174 |
| 102 | MP0000604_amyloidosis | 0.78615712 |
| 103 | MP0004957_abnormal_blastocyst_morpholog | 0.77645700 |
| 104 | MP0000313_abnormal_cell_death | 0.77545212 |
| 105 | MP0002877_abnormal_melanocyte_morpholog | 0.76833795 |
| 106 | MP0009763_increased_sensitivity_to | 0.76521115 |
| 107 | MP0000767_abnormal_smooth_muscle | 0.76335075 |
| 108 | MP0002009_preneoplasia | 0.76214345 |
| 109 | MP0000343_altered_response_to | 0.75974431 |
| 110 | MP0003186_abnormal_redox_activity | 0.75851719 |
| 111 | MP0008961_abnormal_basal_metabolism | 0.75751159 |
| 112 | MP0005666_abnormal_adipose_tissue | 0.73665491 |
| 113 | MP0003828_pulmonary_edema | 0.73376782 |
| 114 | MP0000477_abnormal_intestine_morphology | 0.72443925 |
| 115 | MP0005375_adipose_tissue_phenotype | 0.72151751 |
| 116 | MP0008874_decreased_physiological_sensi | 0.71482548 |
| 117 | MP0000598_abnormal_liver_morphology | 0.71356376 |
| 118 | MP0003795_abnormal_bone_structure | 0.67571473 |
| 119 | MP0005058_abnormal_lysosome_morphology | 0.67541148 |
| 120 | MP0009643_abnormal_urine_homeostasis | 0.65886274 |
| 121 | MP0009931_abnormal_skin_appearance | 0.65881979 |
| 122 | MP0008875_abnormal_xenobiotic_pharmacok | 0.65405601 |
| 123 | MP0002136_abnormal_kidney_physiology | 0.63631781 |
| 124 | MP0005623_abnormal_meninges_morphology | 0.62947083 |
| 125 | MP0001764_abnormal_homeostasis | 0.62313781 |
| 126 | MP0005085_abnormal_gallbladder_physiolo | 0.62056332 |
| 127 | MP0003879_abnormal_hair_cell | 0.59858171 |
| 128 | MP0005377_hearing/vestibular/ear_phenot | 0.59412432 |
| 129 | MP0003878_abnormal_ear_physiology | 0.59412432 |
| 130 | MP0003329_amyloid_beta_deposits | 0.58654030 |
| 131 | MP0003091_abnormal_cell_migration | 0.57672451 |
| 132 | MP0003045_fibrosis | 0.57443417 |
| 133 | MP0001849_ear_inflammation | 0.56608667 |
| 134 | MP0008004_abnormal_stomach_pH | 0.54556779 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.48584974 |
| 2 | Recurrent abscess formation (HP:0002722) | 3.76377513 |
| 3 | Recurrent fungal infections (HP:0002841) | 3.74255306 |
| 4 | Combined immunodeficiency (HP:0005387) | 3.61735679 |
| 5 | Severe combined immunodeficiency (HP:0004430) | 3.53468585 |
| 6 | Eczematoid dermatitis (HP:0000976) | 3.50186301 |
| 7 | Recurrent viral infections (HP:0004429) | 3.36000026 |
| 8 | Myositis (HP:0100614) | 3.25700882 |
| 9 | IgM deficiency (HP:0002850) | 3.23090539 |
| 10 | Abnormality of the fingertips (HP:0001211) | 3.22650278 |
| 11 | Abnormality of T cell number (HP:0011839) | 3.19599509 |
| 12 | T lymphocytopenia (HP:0005403) | 3.18145604 |
| 13 | Recurrent bacterial skin infections (HP:0005406) | 3.15616454 |
| 14 | Chronic otitis media (HP:0000389) | 3.10417628 |
| 15 | Abnormality of T cells (HP:0002843) | 3.10237294 |
| 16 | Polycythemia (HP:0001901) | 3.09834899 |
| 17 | Lymphopenia (HP:0001888) | 3.04447373 |
| 18 | Pustule (HP:0200039) | 3.04217177 |
| 19 | Recurrent bronchitis (HP:0002837) | 3.01304137 |
| 20 | Autoimmune thrombocytopenia (HP:0001973) | 2.99992191 |
| 21 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.96862169 |
| 22 | Nasal polyposis (HP:0100582) | 2.95221696 |
| 23 | Leukocytosis (HP:0001974) | 2.91925921 |
| 24 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.90102465 |
| 25 | Recurrent cutaneous fungal infections (HP:0011370) | 2.90102465 |
| 26 | Colitis (HP:0002583) | 2.86427496 |
| 27 | Inflammation of the large intestine (HP:0002037) | 2.85155854 |
| 28 | Agammaglobulinemia (HP:0004432) | 2.84633115 |
| 29 | Gastrointestinal inflammation (HP:0004386) | 2.83093616 |
| 30 | Panhypogammaglobulinemia (HP:0003139) | 2.82012062 |
| 31 | Abnormality of the nasal mucosa (HP:0000433) | 2.80357686 |
| 32 | Thyroiditis (HP:0100646) | 2.76183907 |
| 33 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.75913640 |
| 34 | Recurrent skin infections (HP:0001581) | 2.69031334 |
| 35 | Orchitis (HP:0100796) | 2.68754778 |
| 36 | Abnormality of eosinophils (HP:0001879) | 2.68579139 |
| 37 | Chronic diarrhea (HP:0002028) | 2.65912357 |
| 38 | Abnormality of T cell physiology (HP:0011840) | 2.62667840 |
| 39 | Vasculitis (HP:0002633) | 2.61295013 |
| 40 | Purpura (HP:0000979) | 2.60687454 |
| 41 | Mediastinal lymphadenopathy (HP:0100721) | 2.55059452 |
| 42 | Thrombocytosis (HP:0001894) | 2.55032502 |
| 43 | Petechiae (HP:0000967) | 2.54161974 |
| 44 | Meningitis (HP:0001287) | 2.54123952 |
| 45 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.45793632 |
| 46 | Hypochromic anemia (HP:0001931) | 2.45436375 |
| 47 | IgG deficiency (HP:0004315) | 2.43882294 |
| 48 | Cellulitis (HP:0100658) | 2.41985814 |
| 49 | Hypertensive crisis (HP:0100735) | 2.40518728 |
| 50 | Recurrent otitis media (HP:0000403) | 2.38767704 |
| 51 | Periodontitis (HP:0000704) | 2.38389335 |
| 52 | Granulocytopenia (HP:0001913) | 2.38276085 |
| 53 | Eosinophilia (HP:0001880) | 2.37471410 |
| 54 | Fatigue (HP:0012378) | 2.36067913 |
| 55 | Increased serum ferritin (HP:0003281) | 2.35139664 |
| 56 | Gingivitis (HP:0000230) | 2.31593339 |
| 57 | Dysostosis multiplex (HP:0000943) | 2.30686320 |
| 58 | Epistaxis (HP:0000421) | 2.30627097 |
| 59 | Stomatitis (HP:0010280) | 2.28426665 |
| 60 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.27169120 |
| 61 | Abnormality of B cell number (HP:0010975) | 2.26901425 |
| 62 | B lymphocytopenia (HP:0010976) | 2.26901425 |
| 63 | Interstitial pulmonary disease (HP:0006530) | 2.25387152 |
| 64 | Recurrent sinusitis (HP:0011108) | 2.25229648 |
| 65 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.21299262 |
| 66 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.19930230 |
| 67 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.19930230 |
| 68 | Abnormality of glycolipid metabolism (HP:0010969) | 2.19930230 |
| 69 | Obstructive sleep apnea (HP:0002870) | 2.19677732 |
| 70 | Increased cerebral lipofuscin (HP:0011813) | 2.19622252 |
| 71 | Prolonged bleeding time (HP:0003010) | 2.18828847 |
| 72 | Keratoconjunctivitis sicca (HP:0001097) | 2.18235567 |
| 73 | Pulmonary infiltrates (HP:0002113) | 2.17823046 |
| 74 | Ureteral stenosis (HP:0000071) | 2.15240223 |
| 75 | Slow saccadic eye movements (HP:0000514) | 2.14357610 |
| 76 | Gingival bleeding (HP:0000225) | 2.13011870 |
| 77 | Hypercortisolism (HP:0001578) | 2.12839457 |
| 78 | Hemoptysis (HP:0002105) | 2.12696372 |
| 79 | Hemorrhage of the eye (HP:0011885) | 2.12086894 |
| 80 | Loss of speech (HP:0002371) | 2.11317654 |
| 81 | Lymphoma (HP:0002665) | 2.09114734 |
| 82 | Cheilitis (HP:0100825) | 2.08889829 |
| 83 | Increased IgE level (HP:0003212) | 2.06487948 |
| 84 | Retrobulbar optic neuritis (HP:0100654) | 2.05791461 |
| 85 | Optic neuritis (HP:0100653) | 2.05791461 |
| 86 | Breech presentation (HP:0001623) | 2.04548975 |
| 87 | Spontaneous hematomas (HP:0007420) | 2.04174182 |
| 88 | Aplastic anemia (HP:0001915) | 2.02948912 |
| 89 | Osteomyelitis (HP:0002754) | 2.02022543 |
| 90 | Keratoconjunctivitis (HP:0001096) | 2.01863353 |
| 91 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.00916386 |
| 92 | Emphysema (HP:0002097) | 2.00239468 |
| 93 | Hypertriglyceridemia (HP:0002155) | 1.99912088 |
| 94 | Polygenic inheritance (HP:0010982) | 1.99585099 |
| 95 | Verrucae (HP:0200043) | 1.99166433 |
| 96 | Papilloma (HP:0012740) | 1.99166433 |
| 97 | Chest pain (HP:0100749) | 1.98857203 |
| 98 | IgA deficiency (HP:0002720) | 1.97875448 |
| 99 | Increased IgM level (HP:0003496) | 1.97432586 |
| 100 | Abnormal platelet function (HP:0011869) | 1.97249398 |
| 101 | Impaired platelet aggregation (HP:0003540) | 1.97249398 |
| 102 | Joint swelling (HP:0001386) | 1.96750952 |
| 103 | Ureteral obstruction (HP:0006000) | 1.95550700 |
| 104 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.94552861 |
| 105 | Abnormality of macrophages (HP:0004311) | 1.93942116 |
| 106 | Skin ulcer (HP:0200042) | 1.93829145 |
| 107 | Hypoplasia of the thymus (HP:0000778) | 1.93401487 |
| 108 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.92163735 |
| 109 | Gastrointestinal stroma tumor (HP:0100723) | 1.92154723 |
| 110 | Hepatosplenomegaly (HP:0001433) | 1.91591600 |
| 111 | Supranuclear gaze palsy (HP:0000605) | 1.91230150 |
| 112 | Autoimmune hemolytic anemia (HP:0001890) | 1.90946463 |
| 113 | Episodic fever (HP:0001954) | 1.90628406 |
| 114 | Pigmentary retinal degeneration (HP:0001146) | 1.90602722 |
| 115 | Congenital stationary night blindness (HP:0007642) | 1.89836372 |
| 116 | Gastrointestinal infarctions (HP:0005244) | 1.89601547 |
| 117 | Pulmonary embolism (HP:0002204) | 1.87969348 |
| 118 | Amyloidosis (HP:0011034) | 1.87642279 |
| 119 | Microcytic anemia (HP:0001935) | 1.86710841 |
| 120 | Arterial thrombosis (HP:0004420) | 1.86124063 |
| 121 | Abnormality of the prostate (HP:0008775) | 1.85755952 |
| 122 | Urticaria (HP:0001025) | 1.85734564 |
| 123 | Hypergammaglobulinemia (HP:0010702) | 1.85591158 |
| 124 | Abnormality of iron homeostasis (HP:0011031) | 1.85379207 |
| 125 | Chronic obstructive pulmonary disease (HP:0006510) | 1.82911991 |
| 126 | Obstructive lung disease (HP:0006536) | 1.82911991 |
| 127 | Encephalitis (HP:0002383) | 1.82447923 |
| 128 | Broad face (HP:0000283) | 1.82342488 |
| 129 | Acne (HP:0001061) | 1.81459698 |
| 130 | Neuronal loss in central nervous system (HP:0002529) | 1.80774441 |
| 131 | Systemic lupus erythematosus (HP:0002725) | 1.80381841 |
| 132 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.80020197 |
| 133 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.80020197 |
| 134 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.80020197 |
| 135 | Restrictive lung disease (HP:0002091) | 1.79970924 |
| 136 | Hypochromic microcytic anemia (HP:0004840) | 1.78574108 |
| 137 | Poikiloderma (HP:0001029) | 1.77532738 |
| 138 | Bronchitis (HP:0012387) | 1.76848715 |
| 139 | Vacuolated lymphocytes (HP:0001922) | 1.76770563 |
| 140 | Amaurosis fugax (HP:0100576) | 1.70932185 |
| 141 | Sepsis (HP:0100806) | 1.69528671 |
| 142 | Abnormality of the intervertebral disk (HP:0005108) | 1.69243520 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TBK1 | 4.13578611 |
| 2 | MAP4K1 | 3.77598774 |
| 3 | PRPF4B | 3.50123526 |
| 4 | IKBKE | 3.45448358 |
| 5 | ERN1 | 3.37763892 |
| 6 | RIPK4 | 3.14522186 |
| 7 | FGFR4 | 2.67590196 |
| 8 | TYK2 | 2.49182703 |
| 9 | TXK | 2.44075914 |
| 10 | MAP3K14 | 2.19530724 |
| 11 | SMG1 | 2.15794668 |
| 12 | STK10 | 2.09670392 |
| 13 | JAK3 | 2.06384582 |
| 14 | MAP3K10 | 2.03350674 |
| 15 | PIM2 | 1.94405553 |
| 16 | CDK12 | 1.93898162 |
| 17 | RIPK1 | 1.93837235 |
| 18 | ZAP70 | 1.92504551 |
| 19 | BLK | 1.90333920 |
| 20 | TNK2 | 1.88736969 |
| 21 | IKBKB | 1.87629926 |
| 22 | GRK6 | 1.77731292 |
| 23 | BTK | 1.74052142 |
| 24 | TAOK3 | 1.72843964 |
| 25 | KDR | 1.72029907 |
| 26 | KIT | 1.66581222 |
| 27 | ITK | 1.60792688 |
| 28 | NME2 | 1.56199855 |
| 29 | IRAK4 | 1.53839031 |
| 30 | JAK1 | 1.47619465 |
| 31 | FES | 1.45101618 |
| 32 | RPS6KA4 | 1.42286519 |
| 33 | TGFBR2 | 1.36001497 |
| 34 | CHUK | 1.28302901 |
| 35 | PIM1 | 1.23139076 |
| 36 | MARK2 | 1.22485208 |
| 37 | TGFBR1 | 1.20175004 |
| 38 | PRKD2 | 1.19872075 |
| 39 | MARK3 | 1.17915349 |
| 40 | TEC | 1.15055344 |
| 41 | LRRK2 | 1.14886812 |
| 42 | MAP3K1 | 1.14671324 |
| 43 | TESK2 | 1.10745478 |
| 44 | ACVR1B | 1.10588345 |
| 45 | FGFR3 | 1.09712384 |
| 46 | SYK | 1.08075477 |
| 47 | CDC42BPA | 1.06949176 |
| 48 | PDPK1 | 1.06342780 |
| 49 | CSF1R | 1.05736775 |
| 50 | EEF2K | 1.05624382 |
| 51 | EIF2AK1 | 1.05496524 |
| 52 | TAOK2 | 1.03444504 |
| 53 | SIK3 | 1.02287966 |
| 54 | MAP3K11 | 1.02096159 |
| 55 | IRAK2 | 1.01908320 |
| 56 | MAP2K3 | 0.99628987 |
| 57 | EPHB1 | 0.99055894 |
| 58 | CSK | 0.98005919 |
| 59 | KSR2 | 0.96735848 |
| 60 | MAP3K13 | 0.95702450 |
| 61 | HIPK2 | 0.92456662 |
| 62 | LCK | 0.90441451 |
| 63 | EPHA3 | 0.83700895 |
| 64 | NEK2 | 0.83202757 |
| 65 | HCK | 0.83059762 |
| 66 | FLT3 | 0.82976456 |
| 67 | MAP3K3 | 0.81310595 |
| 68 | TRIB3 | 0.79528602 |
| 69 | PDK1 | 0.79440856 |
| 70 | CDK4 | 0.77570747 |
| 71 | CAMKK1 | 0.77200704 |
| 72 | LYN | 0.76240851 |
| 73 | CDK7 | 0.75238283 |
| 74 | TAOK1 | 0.74228573 |
| 75 | PKN2 | 0.71620727 |
| 76 | SIK1 | 0.70665771 |
| 77 | MAPK11 | 0.70610060 |
| 78 | ICK | 0.70019657 |
| 79 | MAPK12 | 0.69994502 |
| 80 | MST4 | 0.69921839 |
| 81 | STK4 | 0.69200517 |
| 82 | MAPK7 | 0.68965428 |
| 83 | NLK | 0.68743444 |
| 84 | FGR | 0.68028388 |
| 85 | MAPKAPK3 | 0.67840141 |
| 86 | RPS6KB2 | 0.65225814 |
| 87 | IRAK3 | 0.64213558 |
| 88 | BMPR1B | 0.63115275 |
| 89 | MAP3K8 | 0.61533030 |
| 90 | JAK2 | 0.58605009 |
| 91 | DYRK3 | 0.58581849 |
| 92 | PTK6 | 0.57488403 |
| 93 | PRKD3 | 0.56838776 |
| 94 | DMPK | 0.55007634 |
| 95 | TESK1 | 0.54743004 |
| 96 | ATR | 0.54602140 |
| 97 | DYRK1B | 0.54596820 |
| 98 | ARAF | 0.54109219 |
| 99 | MAPKAPK2 | 0.52910475 |
| 100 | MATK | 0.52717421 |
| 101 | MOS | 0.52195795 |
| 102 | GRK1 | 0.50884067 |
| 103 | RPS6KA5 | 0.50457528 |
| 104 | CLK1 | 0.49888503 |
| 105 | MAP3K7 | 0.49158433 |
| 106 | BRD4 | 0.49115942 |
| 107 | RPS6KA6 | 0.48952976 |
| 108 | PRKCQ | 0.48238171 |
| 109 | RPS6KA2 | 0.47969447 |
| 110 | MTOR | 0.45619073 |
| 111 | SIK2 | 0.44814804 |
| 112 | TTN | 0.44614813 |
| 113 | PAK4 | 0.43307852 |
| 114 | BRAF | 0.41672593 |
| 115 | RPS6KL1 | 0.40386329 |
| 116 | RPS6KC1 | 0.40386329 |
| 117 | IRAK1 | 0.40050425 |
| 118 | STK38 | 0.38702218 |
| 119 | RPS6KA1 | 0.38332982 |
| 120 | MAP2K2 | 0.38099203 |
| 121 | PASK | 0.37156107 |
| 122 | CDK6 | 0.37036280 |
| 123 | MAP3K6 | 0.36616567 |
| 124 | STK11 | 0.35197268 |
| 125 | FYN | 0.34698415 |
| 126 | MAP2K6 | 0.33601776 |
| 127 | MAPK4 | 0.32520155 |
| 128 | MAPK3 | 0.32512555 |
| 129 | YES1 | 0.31943679 |
| 130 | CDK9 | 0.31408132 |
| 131 | BCKDK | 0.30769753 |
| 132 | PRKCI | 0.29794548 |
| 133 | CDK8 | 0.28221130 |
| 134 | PRKG2 | 0.27901370 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.63301986 |
| 2 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.47728034 |
| 3 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.35766405 |
| 4 | Measles_Homo sapiens_hsa05162 | 2.30700977 |
| 5 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.23191569 |
| 6 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.04246150 |
| 7 | Leishmaniasis_Homo sapiens_hsa05140 | 1.98939913 |
| 8 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.96673731 |
| 9 | Base excision repair_Homo sapiens_hsa03410 | 1.91955174 |
| 10 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.90548332 |
| 11 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.90358064 |
| 12 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.81628322 |
| 13 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.68315244 |
| 14 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.60717771 |
| 15 | DNA replication_Homo sapiens_hsa03030 | 1.53862811 |
| 16 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.51633934 |
| 17 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.50921973 |
| 18 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.48956095 |
| 19 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.48859919 |
| 20 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.48552403 |
| 21 | Influenza A_Homo sapiens_hsa05164 | 1.43473960 |
| 22 | Allograft rejection_Homo sapiens_hsa05330 | 1.41111456 |
| 23 | Legionellosis_Homo sapiens_hsa05134 | 1.40443777 |
| 24 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.38344776 |
| 25 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.36307135 |
| 26 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.33472009 |
| 27 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.30338963 |
| 28 | Apoptosis_Homo sapiens_hsa04210 | 1.29966709 |
| 29 | Viral myocarditis_Homo sapiens_hsa05416 | 1.29305196 |
| 30 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.28617654 |
| 31 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.28343294 |
| 32 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.24173955 |
| 33 | Other glycan degradation_Homo sapiens_hsa00511 | 1.22959879 |
| 34 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.21488060 |
| 35 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.17344525 |
| 36 | Hepatitis B_Homo sapiens_hsa05161 | 1.16429985 |
| 37 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.16114150 |
| 38 | Mismatch repair_Homo sapiens_hsa03430 | 1.13851279 |
| 39 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.11006923 |
| 40 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.10786049 |
| 41 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.09422828 |
| 42 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.08494681 |
| 43 | Spliceosome_Homo sapiens_hsa03040 | 1.07251087 |
| 44 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.06813484 |
| 45 | Shigellosis_Homo sapiens_hsa05131 | 1.06209199 |
| 46 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.04853525 |
| 47 | Pertussis_Homo sapiens_hsa05133 | 1.01122781 |
| 48 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.01115931 |
| 49 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.01105883 |
| 50 | Bladder cancer_Homo sapiens_hsa05219 | 1.00997102 |
| 51 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.00647476 |
| 52 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.00393402 |
| 53 | Sulfur relay system_Homo sapiens_hsa04122 | 0.98404323 |
| 54 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.97227028 |
| 55 | Hepatitis C_Homo sapiens_hsa05160 | 0.97129599 |
| 56 | HTLV-I infection_Homo sapiens_hsa05166 | 0.95116169 |
| 57 | Malaria_Homo sapiens_hsa05144 | 0.91886162 |
| 58 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.90996980 |
| 59 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.90721359 |
| 60 | Phagosome_Homo sapiens_hsa04145 | 0.88612453 |
| 61 | Lysosome_Homo sapiens_hsa04142 | 0.85538195 |
| 62 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.84835903 |
| 63 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.83220502 |
| 64 | Asthma_Homo sapiens_hsa05310 | 0.82750798 |
| 65 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.82391952 |
| 66 | Endocytosis_Homo sapiens_hsa04144 | 0.82137324 |
| 67 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.81984729 |
| 68 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.81556438 |
| 69 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.80841762 |
| 70 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.80454093 |
| 71 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.80199063 |
| 72 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.79930436 |
| 73 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.79805276 |
| 74 | Tuberculosis_Homo sapiens_hsa05152 | 0.79130893 |
| 75 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.77889157 |
| 76 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.77798949 |
| 77 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.76689092 |
| 78 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.76563394 |
| 79 | Prion diseases_Homo sapiens_hsa05020 | 0.76280420 |
| 80 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.76141482 |
| 81 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.75376244 |
| 82 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.74348702 |
| 83 | Endometrial cancer_Homo sapiens_hsa05213 | 0.74208297 |
| 84 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.73632378 |
| 85 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.73303279 |
| 86 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.72909737 |
| 87 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.72765892 |
| 88 | Cell cycle_Homo sapiens_hsa04110 | 0.72016359 |
| 89 | ABC transporters_Homo sapiens_hsa02010 | 0.71831100 |
| 90 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.71274019 |
| 91 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.70829489 |
| 92 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.70731966 |
| 93 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.69823556 |
| 94 | Lysine degradation_Homo sapiens_hsa00310 | 0.69457716 |
| 95 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.68999608 |
| 96 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.68500831 |
| 97 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.67829498 |
| 98 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.66820789 |
| 99 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.65456596 |
| 100 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.65257153 |
| 101 | Proteasome_Homo sapiens_hsa03050 | 0.64495788 |
| 102 | Homologous recombination_Homo sapiens_hsa03440 | 0.64476615 |
| 103 | Glioma_Homo sapiens_hsa05214 | 0.63797495 |
| 104 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.62996154 |
| 105 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.60880254 |
| 106 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.60669102 |
| 107 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.60575463 |
| 108 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.60181402 |
| 109 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.59506535 |
| 110 | Ribosome_Homo sapiens_hsa03010 | 0.58705469 |
| 111 | Colorectal cancer_Homo sapiens_hsa05210 | 0.58353818 |
| 112 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.57574796 |
| 113 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.55449053 |
| 114 | RNA transport_Homo sapiens_hsa03013 | 0.53394316 |
| 115 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.52282989 |
| 116 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.52014742 |
| 117 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.51030622 |
| 118 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.50845167 |
| 119 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.50436065 |
| 120 | Amoebiasis_Homo sapiens_hsa05146 | 0.50388921 |
| 121 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.49599101 |
| 122 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.49102864 |
| 123 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.48423051 |
| 124 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.47794735 |
| 125 | Salmonella infection_Homo sapiens_hsa05132 | 0.47405820 |
| 126 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.46950059 |
| 127 | Prostate cancer_Homo sapiens_hsa05215 | 0.46940794 |
| 128 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.46863385 |
| 129 | Phototransduction_Homo sapiens_hsa04744 | 0.46470090 |
| 130 | RNA degradation_Homo sapiens_hsa03018 | 0.44432839 |
| 131 | Galactose metabolism_Homo sapiens_hsa00052 | 0.44140932 |
| 132 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.41448599 |
| 133 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.41050959 |
| 134 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.39449583 |
| 135 | Insulin resistance_Homo sapiens_hsa04931 | 0.39012118 |
| 136 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.38028055 |
| 137 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.37491452 |
| 138 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.37417792 |
| 139 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.36307411 |
| 140 | Platelet activation_Homo sapiens_hsa04611 | 0.35945462 |

